← All verdicts
Verdict

Deep Overvalued

Every analyzed stock in Deep Overvalued1,218 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Deep Overvalued" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

MANH
MANHATTAN ASSOCIATES INC
Deeply overvalued
Technology Risk 55 · Elevated
Price$211.54
Model IV$113.83
P/IV1.32
Premium +86% Return to IV: -46.2%
Market implies +19.8%/yr vs model +14.0% · above model
MAR
MARRIOTT INTERNATIONAL INC /MD/
Deeply overvalued
Consumer Cyclical Risk 54 · Elevated
Price$334.69
Model IV$274.00
P/IV1.37
Premium +22% Return to IV: -18.1%
Market implies +16.9%/yr vs model +18.5% · in line
MASI
MASIMO CORP
Deeply overvalued
Healthcare Risk 52 · Elevated
Price$179.95
Model IV$57.69
P/IV3.09
Premium +212% Return to IV: -67.9%
Market implies +16.8%/yr vs model +2.6% · above model
MATW
MATTHEWS INTERNATIONAL CORP
Deeply overvalued
Basic Materials Risk 67 · High
Price$20.00
Model IV$9.82
P/IV2.70
Premium +104% Return to IV: -50.9%
Market implies +6.9%/yr vs model +0.0% · above model
MATX
Matson, Inc.
Deeply overvalued
Industrials Risk 70 · High
Price$236.62
Model IV$96.00
P/IV1.89
Premium +146% Return to IV: -59.4%
Market implies +15.5%/yr vs model +3.1% · above model
MAYS
MAYS J W INC
Deeply overvalued
Real Estate Risk 58 · Elevated
Price$40.12
Model IV$22.40
P/IV1.91
Premium +79% Return to IV: -44.2%
MBBC
Marathon Bancorp, Inc. /MD/
Deeply overvalued
Financial Services Risk 59 · Elevated
Price$15.00
Model IV$8.15
P/IV1.70
Premium +84% Return to IV: -45.7%
MBLY
Mobileye Global Inc.
Deeply overvalued
Technology Risk 48 · Elevated
Price$8.25
Model IV$3.82
P/IV2.70
Premium +116% Return to IV: -53.7%
Market implies +19.1%/yr vs model +9.3% · above model
MBUU
MALIBU BOATS, INC.
Deeply overvalued
Consumer Cyclical Risk 60 · High
Price$24.89
Model IV$12.16
P/IV2.23
Premium +105% Return to IV: -51.1%
Market implies +13.4%/yr vs model +4.6% · above model
MCHB
Mechanics Bancorp
Deeply overvalued
Financial Services Risk 62 · High
Price$15.37
Model IV$10.95
P/IV1.38
Premium +40% Return to IV: -28.8%
MCHPP
MICROCHIP TECHNOLOGY INC
Deeply overvalued
Technology Risk 62 · High
Price$63.64
Model IV$17.28
P/IV4.64
Premium +268% Return to IV: -72.8%
Market implies +15.9%/yr vs model -1.7% · above model
MCO
MOODYS CORP /DE/
Deeply overvalued
Technology Risk 64 · High
Price$477.93
Model IV$277.00
P/IV1.64
Premium +73% Return to IV: -42.0%
Market implies +14.2%/yr vs model +8.6% · above model
MCY
MERCURY GENERAL CORP
Deeply overvalued
Financial Services Risk 61 · High
Price$102.34
Model IV$59.02
P/IV1.66
Premium +73% Return to IV: -42.3%
MDAI
Spectral AI, Inc.
Deeply overvalued
Healthcare Risk 68 · High
Price$1.60
Model IV$0.82
P/IV2.54
Premium +96% Return to IV: -49.0%
Market implies +6.4%/yr vs model +15.0% · below model
MDB
MongoDB, Inc.
Deeply overvalued
Technology Risk 57 · Elevated
Price$362.21
Model IV$124.17
P/IV2.70
Premium +192% Return to IV: -65.7%
Market implies +17.1%/yr vs model +29.6% · below model
MDGL
MADRIGAL PHARMACEUTICALS, INC.
Deeply overvalued
Healthcare Risk 58 · Elevated
Price$523.26
Model IV$135.61
P/IV3.67
Premium +286% Return to IV: -74.1%
Market implies +10.3%/yr vs model +15.0% · below model
MDRR
Medalist Diversified, Inc.
Deeply overvalued
Financial Services Risk 58 · Elevated
Price$11.62
Model IV$4.78
P/IV2.28
Premium +143% Return to IV: -58.9%
MDU
MDU RESOURCES GROUP INC
Deeply overvalued
Basic Materials Risk 51 · Elevated
Price$19.20
Model IV$11.76
P/IV1.79
Premium +63% Return to IV: -38.8%
Market implies +3.5%/yr vs model +0.0% · above model
MDV
MODIV INDUSTRIAL, INC.
Deeply overvalued
Financial Services Risk 60 · High
Price$18.13
Model IV$8.13
P/IV2.23
Premium +123% Return to IV: -55.2%
MEC
Mayville Engineering Company, Inc.
Overvalued
Industrials Risk 63 · High
Price$18.09
Model IV$15.57
P/IV1.72
Premium +16% Return to IV: -13.9%
Market implies +5.4%/yr vs model +5.1% · in line
MEGL
Magic Empire Global Ltd
Deeply overvalued
Financial Services Risk 53 · Elevated
Price$1.18
Model IV$0.32
P/IV3.72
Premium +266% Return to IV: -72.7%
Market implies +9.4%/yr vs model +15.0% · below model
MET
METLIFE INC
Deeply overvalued
Financial Services Risk 67 · High
Price$97.14
Model IV$60.87
P/IV1.36
Premium +60% Return to IV: -37.3%
META
Meta Platforms, Inc.
Deeply overvalued
Technology Risk 55 · Elevated
Price$670.24
Model IV$263.70
P/IV2.40
Premium +154% Return to IV: -60.7%
Market implies +26.0%/yr vs model +16.2% · above model
MGLD
Marygold Companies, Inc.
Deeply overvalued
Financial Services Risk 58 · Elevated
Price$0.98
Model IV$0.59
P/IV1.94
Premium +65% Return to IV: -39.5%
Market implies -2.9%/yr vs model +2.0% · below model
MGN
Megan Holdings Ltd.
Deeply overvalued
Basic Materials Risk 59 · Elevated
Price$0.13
Model IV$0.07
P/IV2.18
Premium +91% Return to IV: -47.6%
Market implies +9.4%/yr vs model +5.0% · above model
MGNI
MAGNITE, INC.
Deeply overvalued
Technology Risk 54 · Elevated
Price$23.77
Model IV$10.15
P/IV1.41
Premium +134% Return to IV: -57.3%
Market implies +21.2%/yr vs model +11.4% · above model
MGNX
MACROGENICS INC
Deeply overvalued
Healthcare Risk 62 · High
Price$4.00
Model IV$2.64
P/IV1.57
Premium +51% Return to IV: -33.9%
Market implies +3.8%/yr vs model +17.9% · below model
MGRT
Mega Fortune Co Ltd
Valuation N/A
Technology Risk 60 · High
Price$120.00
Model IV
P/IV
Market implies +16.8%/yr vs model +50.0% · below model
MGRX
MANGOCEUTICALS, INC.
Deeply overvalued
Healthcare Risk 61 · High
Price$0.42
Model IV$0.13
P/IV3.37
Premium +229% Return to IV: -69.6%
Market implies +18.0%/yr vs model +50.0% · below model
MIDD
MIDDLEBY Corp
Deeply overvalued
Industrials Risk 62 · High
Price$108.31
Model IV$89.83
P/IV1.73
Premium +21% Return to IV: -17.1%
Market implies -0.5%/yr vs model -1.7% · in line
MITK
MITEK SYSTEMS INC
Deeply overvalued
Technology Risk 61 · High
Price$17.22
Model IV$8.40
P/IV2.05
Premium +105% Return to IV: -51.2%
Market implies +18.1%/yr vs model +11.1% · above model
MKSI
MKS INC
Deeply overvalued
Healthcare Risk 61 · High
Price$267.31
Model IV$71.04
P/IV4.56
Premium +276% Return to IV: -73.4%
Market implies +27.0%/yr vs model +8.2% · above model
MLCIL
Mount Logan Capital Inc.
Deeply overvalued
Financial Services Risk 51 · Elevated
Price$22.45
Model IV$9.72
P/IV2.36
Premium +131% Return to IV: -56.7%
Market implies +0.9%/yr vs model +7.6% · below model
MLGO
MicroAlgo Inc.
Deeply overvalued
Technology Risk 50 · Elevated
Price$3.65
Model IV$1.58
P/IV3.81
Premium +131% Return to IV: -56.7%
Market implies +8.8%/yr vs model -1.7% · above model
MLI
MUELLER INDUSTRIES INC
Deeply overvalued
Basic Materials Risk 60 · High
Price$60.48
Model IV$63.80
P/IV2.02
Discount 5% Return to IV: +5.5%
Market implies +2.2%/yr vs model +3.3% · in line
MLM
MARTIN MARIETTA MATERIALS INC
Deeply overvalued
Basic Materials Risk 59 · Elevated
Price$500.92
Model IV$193.83
P/IV3.00
Premium +158% Return to IV: -61.3%
Market implies +16.1%/yr vs model +3.8% · above model
MMI
Marcus & Millichap, Inc.
Deeply overvalued
Real Estate Risk 67 · High
Price$31.27
Model IV$10.57
P/IV1.68
Premium +196% Return to IV: -66.2%
Market implies +13.6%/yr vs model +2.0% · above model
MNTK
Montauk Renewables, Inc.
Deeply overvalued
Utilities Risk 55 · Elevated
Price$2.22
Model IV$0.47
P/IV3.72
Premium +374% Return to IV: -78.9%
MOBX
MOBIX LABS, INC
Overvalued
Technology Risk 53 · Elevated
Price$1.11
Model IV$0.86
P/IV2.80
Premium +29% Return to IV: -22.7%
Market implies -5.7%/yr vs model +15.0% · below model
MOMO
Hello Group Inc.
Deeply overvalued
Technology Risk 60 · High
Price$4.95
Model IV$2.39
P/IV2.49
Premium +107% Return to IV: -51.7%
Market implies +10.4%/yr vs model +0.4% · above model
MOV
MOVADO GROUP INC
Deeply overvalued
Consumer Cyclical Risk 64 · High
Price$33.28
Model IV$24.93
P/IV1.54
Premium +33% Return to IV: -25.1%
Market implies +6.8%/yr vs model +4.1% · in line
MPT
MEDICAL PROPERTIES TRUST INC
Overvalued
Financial Services Risk 73 · High
Price$3.54
Model IV$2.96
P/IV1.73
Premium +20% Return to IV: -16.4%
MPTI
M-tron Industries, Inc.
Deeply overvalued
Technology Risk 61 · High
Price$79.49
Model IV$45.23
P/IV2.01
Premium +76% Return to IV: -43.1%
Market implies +20.5%/yr vs model +17.2% · above model
MQ
Marqeta, Inc.
Valuation N/A
Technology Risk 55 · Elevated
Price$16.33
Model IV
P/IV
Market implies +32.3%/yr vs model +7.0% · above model
MRKR
Marker Therapeutics, Inc.
Deeply overvalued
Healthcare Risk 53 · Elevated
Price$1.17
Model IV$0.56
P/IV2.79
Premium +108% Return to IV: -51.9%
Market implies +4.5%/yr vs model +30.0% · below model
MSB
MESABI TRUST
Deeply overvalued
Financial Services Risk 60 · High
Price$20.54
Model IV$12.83
P/IV2.06
Premium +60% Return to IV: -37.5%
MSBI
Midland States Bancorp, Inc.
Deeply overvalued
Financial Services Risk 68 · High
Price$33.59
Model IV$14.38
P/IV1.93
Premium +134% Return to IV: -57.2%
MSBIP
Midland States Bancorp, Inc.
Deeply overvalued
Financial Services Risk 58 · Elevated
Price$25.60
Model IV$15.66
P/IV1.63
Premium +63% Return to IV: -38.8%
MSDL
Morgan Stanley Direct Lending Fund
Deeply overvalued
Unknown Risk 54 · Elevated
Price$14.71
Model IV$11.60
P/IV1.33
Premium +27% Return to IV: -21.2%
Market implies -6.9%/yr vs model -8.7% · in line
MSFT
MICROSOFT CORP
Deeply overvalued
Technology Risk 53 · Elevated
Price$505.41
Model IV$224.20
P/IV2.01
Premium +125% Return to IV: -55.6%
Market implies +22.2%/yr vs model +13.3% · above model
MSGS
Madison Square Garden Sports Corp.
Deeply overvalued
Communication Services Risk 65 · High
Price$392.07
Model IV$138.83
P/IV2.70
Premium +182% Return to IV: -64.6%
Market implies +29.4%/yr vs model +20.4% · above model
MSGY
Masonglory Ltd
Valuation N/A
Industrials Risk 28 · Moderate
Price$2.08
Model IV
P/IV
Market implies +50.6%/yr vs model +25.0% · above model
MSM
MSC INDUSTRIAL DIRECT CO INC
Deeply overvalued
Industrials Risk 55 · Elevated
Price$119.88
Model IV$72.56
P/IV1.51
Premium +65% Return to IV: -39.5%
Market implies +10.6%/yr vs model +4.5% · above model
MTD
METTLER TOLEDO INTERNATIONAL INC/
Deeply overvalued
Healthcare Risk 51 · Elevated
Price$1,293.52
Model IV$792.57
P/IV1.49
Premium +63% Return to IV: -38.7%
Market implies +12.9%/yr vs model +7.5% · above model
MTRN
MATERION Corp
Deeply overvalued
Industrials Risk 54 · Elevated
Price$240.22
Model IV$49.28
P/IV4.46
Premium +387% Return to IV: -79.5%
Market implies +27.3%/yr vs model +4.8% · above model
MTZ
MASTEC INC
Fairly valued
Industrials Risk 62 · High
Price$227.70
Model IV$226.30
P/IV1.67
Premium +1% Return to IV: -0.6%
Market implies +2.1%/yr vs model +15.8% · below model
MWA
Mueller Water Products, Inc.
Deeply overvalued
Industrials Risk 54 · Elevated
Price$23.94
Model IV$18.60
P/IV1.36
Premium +29% Return to IV: -22.3%
Market implies +8.7%/yr vs model +6.4% · in line
MWYN
Marwynn Holdings, Inc.
Deeply overvalued
Consumer Defensive Risk 53 · Elevated
Price$0.93
Model IV$0.29
P/IV2.84
Premium +226% Return to IV: -69.4%
Market implies +3.9%/yr vs model +2.0% · in line
MYFW
First Western Financial Inc
Deeply overvalued
Financial Services Risk 64 · High
Price$30.99
Model IV$17.79
P/IV1.64
Premium +74% Return to IV: -42.6%
MYO
MYOMO, INC.
Overvalued
Healthcare Risk 58 · Elevated
Price$1.24
Model IV$0.97
P/IV1.59
Premium +28% Return to IV: -21.9%
Market implies +1.2%/yr vs model +15.0% · below model